WIRELESS SENSOR SYSTEM FOR IMPLEMENTATION OF SMART SPACES

This paper describes the design, implementation and application of a smart sensor system based in wireless communication protocol, which was developed with the main objective of facilitate the implementation of smart places, whereby monitoring and supervision of environmental physical variables in a residence or commercial buildings. Based in this system, we want to co-help taking advantage and save electric energy, optimizing the use of the lighting systems and air conditioner only in the schedules and under pre-established conditions for the final user. The system is based in a variety of nodes o modules of sensors like temperature, humidity, light, carbon monoxide, noise and LP gas which have the ability to work collaboratively in networks with topologies like star, tree and mesh

Sistema de sensores inalámbricos para la implementación de espacios inteligentes

El presente trabajo describe el diseño, construcción y aplicación de un sistema de sensores inteligentes basado en comunicación inalámbrica, desarrollado con la finalidad de facilitar la implementación de espacios inteligentes, mediante el cual, sea posible el monitoreo y supervisión de las variables físicas ambientales en una residencia o edificio comercial. Con dicho sistema, se pretende coadyuvar en el aprovechamiento y ahorro de energía eléctrica, optimizando el uso de los sistemas de iluminación y aire acondicionado solo en los horarios y condiciones preestablecidas por el usuario final. El sistema integra una variedad de módulos de sensores de Temperatura, humedad, iluminación, monóxido de carbono, gas LP, presencia y ruido, los cuales tienen la capacidad de trabajar de forma colaborativa en redes con topologías en estrella, árbol y malla

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

International audienceIn this article, the name of the GLORIA-AF investigator Anastasios Kollias was given incorrectly as Athanasios Kollias in the Acknowledgements. The original article has been corrected

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Background: Previous studies suggested potential ethnic differences in the management and outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription, discontinuation, and risk of adverse outcomes in Asian patients with AF, using data from a global prospective cohort study. Methods: From the GLORIA-AF Registry Phase II-III (November 2011-December 2014 for Phase II, and January 2014-December 2016 for Phase III), we analysed patients according to their self-reported ethnicity (Asian vs. non-Asian), as well as according to Asian subgroups (Chinese, Japanese, Korean and other Asian). Logistic regression was used to analyse OAC prescription, while the risk of OAC discontinuation and adverse outcomes were analysed through Cox-regression model. Our primary outcome was the composite of all-cause death and major adverse cardiovascular events (MACE). The original studies were registered with ClinicalTrials.gov, NCT01468701, NCT01671007, and NCT01937377. Findings: 34,421 patients were included (70.0 ± 10.5 years, 45.1% females, 6900 (20.0%) Asian: 3829 (55.5%) Chinese, 814 (11.8%) Japanese, 1964 (28.5%) Korean and 293 (4.2%) other Asian). Most of the Asian patients were recruited in Asia (n = 6701, 97.1%), while non-Asian patients were mainly recruited in Europe (n = 15,449, 56.1%) and North America (n = 8378, 30.4%). Compared to non-Asian individuals, prescription of OAC and non-vitamin K antagonist oral anticoagulant (NOAC) was lower in Asian patients (Odds Ratio [OR] and 95% Confidence Intervals (CI): 0.23 [0.22-0.25] and 0.66 [0.61-0.71], respectively), but higher in the Japanese subgroup. Asian ethnicity was also associated with higher risk of OAC discontinuation (Hazard Ratio [HR] and [95% CI]: 1.79 [1.67-1.92]), and lower risk of the primary composite outcome (HR [95% CI]: 0.86 [0.76-0.96]). Among the exploratory secondary outcomes, Asian ethnicity was associated with higher risks of thromboembolism and intracranial haemorrhage, and lower risk of major bleeding. Interpretation: Our results showed that Asian patients with AF showed suboptimal thromboembolic risk management and a specific risk profile of adverse outcomes; these differences may also reflect differences in country-specific factors. Ensuring integrated and appropriate treatment of these patients is crucial to improve their prognosis. Funding: The GLORIA-AF Registry was funded by Boehringer Ingelheim GmbH